RE: Belluscura28 Nov 2020 10:35
Nice one thanks.
All I’d say is the board do not have a history of over promising here other than the fda delay which I can understand given supply chain delays. The small placing at 300k gives a hint and I’m fully expecting FDA clearance by year end. It really wouldn’t be worth the backlash and they’ve clearly stated in twice within the placing RNS. Once confirmation lands I’d expect a reasonable sp of 20p plus and then onwards from there.